Skip to main content

and
  1. Article

    Open Access

    Targeting GD2 after allogeneic SCT: effector cell composition defines the optimal use of ch14.18 and the bispecific antibody construct NG-CU (GD2-CD3)

    We investigated whether T cell-recruiting bispecific anti-CD3/GD2 antibody NG-CU might be an alternative to therapeutic anti-GD2 monoclonal antibody (mAb) ch14.18, mediating complement-dependent cytotoxicity (...

    A.-M. Arendt, F. Heubach, C. P. Maier, S. Giardino in Cancer Immunology, Immunotherapy (2023)

  2. No Access

    Article

    Successful management of cutaneous BCG dissemination in a child affected by SCID and receiving allogeneic hematopoietic stem cell transplant

    A Naselli, G Losurdo, S Giardino, G Morreale, C Savioli in Bone Marrow Transplantation (2015)

  3. No Access

    Article

    Bacteremias and invasive fungal diseases in children receiving etanercept for steroid-resistant acute GVHD

    M Faraci, E Lanino, G Morreale, S Giardino, M Fossati in Bone Marrow Transplantation (2011)

  4. No Access

    Article

    Viral-load and B-lymphocyte monitoring of EBV reactivation after allogeneic hemopoietic SCT in children

    EBV-associated post transplant lymphoproliferative disease (EBV-PTLD) is a life-threatening complication that may occur after hemopoietic SCT. We prospectively screened 80 children on a weekly basis using nest...

    M Faraci, I Caviglia, G Morreale, E Lanino, D Cuzzubbo in Bone Marrow Transplantation (2010)

  5. No Access

    Article

    Daclizumab as useful treatment in refractory acute GVHD: a paediatric experience

    GVHD remains a serious complication after allogeneic SCT. We describe 13 paediatric patients treated with daclizumab for refractory acute GVHD (aGVHD). After 30 days of daclizumab administration, all patients ...

    M Miano, D Cuzzubbo, P Terranova, S Giardino, E Lanino in Bone Marrow Transplantation (2009)

  6. No Access

    Article

    Strategies of the donor search for children with second CR ALL lacking a matched sibling donor

    During the last 10 years, the number of alternative Haematopoietic stem cell transplantations (HSCTs) performed on children in Europe has increased significantly and has reached 61% of the allografts. In this ...

    E Lanino, N Sacchi, C Peters, S Giardino, V Rocha, G Dini in Bone Marrow Transplantation (2008)